ELOX

ELOXX PHARMACEUTICALS INC by Eloxx Pharmaceuticals, Inc. (ELOX)

About ELOXX PHARMACEUTICALS INC by Eloxx Pharmaceuticals, Inc. (ELOX)

Eloxx Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of novel ribonucleic acid-modulating drug candidates. It focuses on the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Arlington, MA.

Details

Daily high

$18.59

Daily low

$16.50

Price at open

$17.41

52 Week High

$19.36

52 Week Low

$0.00

Market cap

749,800

Dividend yield

0.00%

Volume

20,529

Avg. volume

69,449

P/E ratio

ELOXX PHARMACEUTICALS INC by Eloxx Pharmaceuticals, Inc. News